Free Trial

1,307 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Allium Financial Advisors LLC

UnitedHealth Group logo with Medical background

Key Points

  • Allium Financial Advisors LLC has invested approximately $685,000 in UnitedHealth Group, acquiring 1,307 shares, which constitutes 0.6% of their investment portfolio, making it their 26th largest position.
  • Insider trading was reported, with CFO John F. Rex purchasing 17,175 shares at an average price of $291.12, increasing his ownership by 9.20% and indicating strong confidence in the company.
  • UnitedHealth recently increased its quarterly dividend from $2.10 to $2.21 per share, representing an annualized dividend yield of 3.15% and demonstrating a commitment to returning value to shareholders.
  • MarketBeat previews top five stocks to own in September.

Allium Financial Advisors LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,307 shares of the healthcare conglomerate's stock, valued at approximately $685,000. UnitedHealth Group makes up about 0.6% of Allium Financial Advisors LLC's investment portfolio, making the stock its 26th largest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Security Financial Services INC. increased its stake in shares of UnitedHealth Group by 9.7% in the first quarter. Security Financial Services INC. now owns 984 shares of the healthcare conglomerate's stock valued at $515,000 after buying an additional 87 shares during the period. FourThought Financial Partners LLC boosted its holdings in UnitedHealth Group by 1.3% in the first quarter. FourThought Financial Partners LLC now owns 18,192 shares of the healthcare conglomerate's stock worth $9,528,000 after acquiring an additional 233 shares in the last quarter. Motco lifted its holdings in shares of UnitedHealth Group by 4.0% in the first quarter. Motco now owns 19,299 shares of the healthcare conglomerate's stock valued at $10,108,000 after purchasing an additional 751 shares in the last quarter. Integrated Investment Consultants LLC lifted its holdings in UnitedHealth Group by 64.7% during the first quarter. Integrated Investment Consultants LLC now owns 2,644 shares of the healthcare conglomerate's stock worth $1,385,000 after acquiring an additional 1,039 shares during the period. Finally, HB Wealth Management LLC lifted its holdings in UnitedHealth Group by 24.6% during the first quarter. HB Wealth Management LLC now owns 64,780 shares of the healthcare conglomerate's stock worth $33,929,000 after acquiring an additional 12,794 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on UNH. TD Securities restated a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. HSBC reiterated a "reduce" rating and issued a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Deutsche Bank Aktiengesellschaft reduced their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Finally, Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $392.29.

Read Our Latest Research Report on UNH

UnitedHealth Group Stock Down 5.0%

Shares of UnitedHealth Group stock traded down $14.01 during midday trading on Tuesday, hitting $268.11. The company had a trading volume of 26,908,385 shares, compared to its average volume of 11,486,181. The company has a 50 day moving average of $300.91 and a 200 day moving average of $422.56. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The stock has a market capitalization of $243.21 billion, a P/E ratio of 11.22, a P/E/G ratio of 1.39 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $5.16 by ($1.08). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the previous year, the company earned $6.80 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.30%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock valued at $31,607,768 in the last ninety days. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines